Jefferies Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-76,100
| Closed | -$805K | – | 1160 |
|
|
2022
Q2 | $805K | Buy |
+76,100
| New | +$805K | 0.01% | 492 |
|
|
2021
Q2 | – | Sell |
-6,430
| Closed | -$65.4K | – | 1112 |
|
|
2021
Q1 | $65.4K | Buy |
+6,430
| New | +$65.4K | ﹤0.01% | 993 |
|
|
2020
Q2 | – | Sell |
-18,829
| Closed | -$38K | – | 828 |
|
|
2020
Q1 | $38K | Sell |
18,829
-296,171
| -94% | -$598K | ﹤0.01% | 1015 |
|
|
2019
Q4 | $1.09M | Buy |
+315,000
| New | +$1.09M | 0.01% | 748 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1504 |
|
|
2016
Q4 | – | Sell |
-1,200
| Closed | -$5K | – | 1335 |
|
|
2016
Q3 | $5K | Buy |
+1,200
| New | +$5K | ﹤0.01% | 1252 |
|